Are crops obtained using CRISPR-Cas safe to eat? And are new genomic techniques really needed to achieve food security, or will they mostly benefit large companies? These are just a few examples of questions that often come up in the complex discussion surrounding CRISPR-Cas. This summer, the European Commission delivered a draft proposal which advises more flexibility in regulations surrounding new genomic techniques. Based on this proposal, crops obtained using these techniques may become more available to the European market. That makes questions like these all the more relevant...